Enhanced RBC Aggregation in Type 2 Diabetes Patients

被引:18
|
作者
Li, Qing [1 ]
Li, Li [2 ]
Li, Yong [1 ]
机构
[1] Shanghai Ctr Clin Lab, Shanghai, Peoples R China
[2] Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China
关键词
erythrocyte sedimentation rate; RBC aggregation; HbA(1c); T2DM; BLOOD-CELL AGGREGATION; ERYTHROCYTE AGGREGATION; GLYCOSYLATED HEMOGLOBIN; SEDIMENTATION-RATE; MELLITUS;
D O I
10.1002/jcla.21784
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: This study aimed to investigate the relationship between HbA(1c) and RBC aggregation in type 2 diabetes mellitus (T2DM) patients by analysis of data from routine clinical tests and from in vitro experiments. Methods: A total of 2,111 inpatients with type 2 diabetes were selected and among them, 364 patients (Group A) had limited influence of plasma proteins on erythrocyte sedimentation rate (ESR) and was compared with the rest of the 1,747 inpatients (Group B). ESR, HbA(1c), WBC, CRP, Fbg, and HCT were measured in all samples. Sixty samples were also collected from T2DM patients and used for in vitro ESR studies. Spearman's correlation coefficients were employed to reflect the correlation between ESR and other parameters. Mann-Whitney U test was used to compare the study parameters. Results: The test results for Group A were lower than Group B with respect to ESR, age, HCT, HbA(1c), CRP, WBC, and Fbg. Only the difference in HbA(1c), CRP, and Fbg values had statistical significance (P < 0.05). In addition, HbA(1c) correlated better with ESR for Group A (R = 0.622) than Group B (R = 0.563), whereas CRP and Fbg were contrary to this. In the in vitro studies, the HbA(1c) values were classified into the subgroups of 6.5-8.0%, 8.1-10%, and > 10%. The corresponding ESR values were 28 +/- 5.1 mm/h, 33 +/- 2.7 mm/h, and 40 +/- 4.1 mm/h, respectively. Conclusion: ESR results of T2DM patients were elevated that was mainly caused by Fbg levels, and in addition HbA(1c) in part contributed to RBC aggregation. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:387 / 389
页数:3
相关论文
共 50 条
  • [31] The therapeutic efficacy of rosiglitazone is enhanced in sulphonylurea-treated patients with type 2 diabetes
    Itakura, H.
    Abbasi, F.
    Lamendola, C.
    Basina, M.
    Reaven, G.
    DIABETES OBESITY & METABOLISM, 2008, 10 (08): : 685 - 687
  • [32] Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
    Rossing, K
    Schjoedt, KJ
    Jensen, BR
    Boomsma, F
    Parving, HH
    KIDNEY INTERNATIONAL, 2005, 68 (03) : 1190 - 1198
  • [33] Enhanced Platelet Sensitivity to IGF-1 in Patients with Type 2 Diabetes Mellitus
    Gligorijevic, N.
    Robajac, D.
    Nedic, O.
    BIOCHEMISTRY-MOSCOW, 2019, 84 (10) : 1213 - 1219
  • [34] Enhanced proliferation in colorectal epithelium of patients with type 2 diabetes correlates with β-catenin accumulation
    Li, Jie-Yao
    Yu, Tao
    Xia, Zhong-Sheng
    Chen, Guang-Cheng
    Yuan, Yu-Hong
    Zhong, Wa
    Zhao, Li-Na
    Chen, Qi-Kui
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (05) : 689 - 697
  • [35] Enhanced Platelet Sensitivity to IGF-1 in Patients with Type 2 Diabetes Mellitus
    N. Gligorijevic
    D. Robajac
    O. Nedic
    Biochemistry (Moscow), 2019, 84 : 1213 - 1219
  • [36] Enhanced syndecan-1 expression on neutrophils in patients with type 2 diabetes mellitus
    Wang, Jing-Bo
    Zhang, Yan-Jun
    Guan, Juan
    Zhou, Li
    Sheng, Yu
    Zhang, Yan
    Si, Yan-Fang
    ACTA DIABETOLOGICA, 2012, 49 (01) : 41 - 46
  • [37] Enhanced Outcomes in Type 2 Diabetes Patients With Acute Kidney Disease Through Thiazolidinedione
    Chang, Li-Yang
    Liao, Hung-Wei
    Chen, Jui-Yi
    Wu, Vin-Cent
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [38] Enhanced syndecan-1 expression on neutrophils in patients with type 2 diabetes mellitus
    Jing-Bo Wang
    Yan-Jun Zhang
    Juan Guan
    Li Zhou
    Yu Sheng
    Yan Zhang
    Yan-Fang Si
    Acta Diabetologica, 2012, 49 : 41 - 46
  • [39] Enhanced carbohydrate craving in patients with poorly controlled Type2 diabetes mellitus
    Yu, J. H.
    Shin, M. S.
    Kim, D. J.
    Lee, J. R.
    Yoon, S. -Y.
    Kim, S. G.
    Koh, E. H.
    Lee, W. J.
    Park, J. -Y.
    Kim, M. -S.
    DIABETIC MEDICINE, 2013, 30 (09) : 1080 - 1086
  • [40] Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus
    Hoseini-Aghdam, Mirhamed
    Sheikh, Vida
    Eftekharian, Mohammad Mahdi
    Rezaeepoor, Mahsa
    Behzad, Mahdi
    IMMUNOLOGY LETTERS, 2020, 225 : 1 - 8